146 related articles for article (PubMed ID: 12894875)
1. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region.
Boćko D; Bilińska M; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Gruszka E; Frydecka I
Arch Immunol Ther Exp (Warsz); 2003; 51(3):201-5. PubMed ID: 12894875
[TBL] [Abstract][Full Text] [Related]
2. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region.
Frydecka I; Daroszewski J; Suwalska K; Zołedziowska M; Tutak A; Słowik M; Potoczek S; Dobosz T
Arch Immunol Ther Exp (Warsz); 2004; 52(5):369-74. PubMed ID: 15507878
[TBL] [Abstract][Full Text] [Related]
4. Association of the A/G polymorphism at position 49 in exon 1 of CTLA-4 with the susceptibility to unexplained recurrent spontaneous abortion in the Chinese population.
Wang X; Lin Q; Ma Z; Hong Y; Zhao A; Di W; Lu P
Am J Reprod Immunol; 2005 Feb; 53(2):100-5. PubMed ID: 15790344
[TBL] [Abstract][Full Text] [Related]
5. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of CTLA-4 exon 1 A49-->G polymorphism with sCTLA-4 and Th1/Th2 bias in idiopathic dilated cardiomyopathy].
Liu W; Li WM; Gao C; Wang XR; Li DM; Sun NL
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3221-4. PubMed ID: 16405845
[TBL] [Abstract][Full Text] [Related]
8. Association of CTLA-4 gene polymorphism with oral submucous fibrosis in Taiwan.
Shin YN; Liu CJ; Chang KW; Lee YJ; Liu HF
J Oral Pathol Med; 2004 Apr; 33(4):200-3. PubMed ID: 15061706
[TBL] [Abstract][Full Text] [Related]
9. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.
Teutsch SM; Booth DR; Bennetts BH; Heard RN; Stewart GJ
J Neuroimmunol; 2004 Mar; 148(1-2):218-30. PubMed ID: 14975605
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians.
Mojtahedi Z; Omrani GR; Doroudchi M; Ghaderi A
Diabetes Res Clin Pract; 2005 May; 68(2):111-6. PubMed ID: 15860238
[TBL] [Abstract][Full Text] [Related]
11. [The frequency of CTLA-4 gene polymorphism at position 49 exon 1 in children with Hashimoto's thyroiditis].
Kucharska A; Wiśniewska A; Rymkiewicz-Kluczyńska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):163-6. PubMed ID: 17020648
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte antigen-4 gene in breast cancer.
Ghaderi A; Yeganeh F; Kalantari T; Talei AR; Pezeshki AM; Doroudchi M; Dehaghani AS
Breast Cancer Res Treat; 2004 Jul; 86(1):1-7. PubMed ID: 15218356
[TBL] [Abstract][Full Text] [Related]
13. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis.
Bagos PG; Karnaouri AC; Nikolopoulos GK; Hamodrakas SJ
Mult Scler; 2007 Mar; 13(2):156-68. PubMed ID: 17439880
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
15. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population.
Almasi S; Erfani N; Mojtahedi Z; Rajaee A; Ghaderi A
Genes Immun; 2006 Jul; 7(5):401-6. PubMed ID: 16775619
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians].
Andreevskiĭ TV; Sudomoina MA; Gusev EI; Boĭko AN; Alekseenkov AD; Favorova OO
Mol Biol (Mosk); 2002; 36(4):643-8. PubMed ID: 12173468
[TBL] [Abstract][Full Text] [Related]
17. Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma.
Wong YK; Chang KW; Cheng CY; Liu CJ
J Oral Pathol Med; 2006 Jan; 35(1):51-4. PubMed ID: 16393254
[TBL] [Abstract][Full Text] [Related]
18. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.
Barton A; Jury F; Eyre S; Bowes J; Hinks A; Ward D; Worthington J
Arthritis Rheum; 2004 Mar; 50(3):748-52. PubMed ID: 15022315
[TBL] [Abstract][Full Text] [Related]
19. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.
Suppiah V; Alloza I; Heggarty S; Goris A; Dubois B; Carton H; Vandenbroeck K
J Neuroimmunol; 2005 Jul; 164(1-2):148-53. PubMed ID: 15904974
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 gene polymorphisms (-318C/T, +49A/G, +6230A/G) in Iranian patients with multiple sclerosis.
Heidari A; Noori Daloii MR; Keramatipour M; Rashikinezhad A; Sahmani AA; Amirzargar AA
Iran J Allergy Asthma Immunol; 2010 Dec; 9(4):219-23. PubMed ID: 21131701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
